Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia.
Authors: Salceda-Rivera V; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico., Ortiz-Lazareno PC; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Hernández-Flores G; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico., Vazquez-Urrutia JR; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Centro Universitario de Ciencias de la Salud, School of Medicine, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Meza-Arroyo J; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Pardo-Zepeda M; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico., Romo-Rubio H; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico., Barba-Barba C; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico., Sánchez-Zubieta F; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.; Departamento de Clinicas de Reproduccion Humana, Crecimiento y Desarrollo Infantil, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Barrón-Gallardo CA; Departamento Académico de Disciplinas Especializantes de Ciencias de la Salud, Universidad Autonoma de Guadalajara, Zapopan, JAL, Mexico., Gonzalez-Ramella O; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.; Centro Universitario de Ciencias de la Salud, School of Medicine, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Bravo-Cuellar A; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos, JAL, Mexico.
Source: Frontiers in oncology [Front Oncol] 2024 Oct 03; Vol. 14, pp. 1401262. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1401262